
HeartFlow, Inc., a company specializing in AI-driven 3D heart modeling for coronary artery disease diagnostics, has seen its stock rally strongly since its August IPO, defying typical post-IPO declines. The company is achieving 50% sales growth but has yet to reach profitability. Despite this, it enjoys strong support from analysts. However, the stock experienced a significant selloff following its Q3 earnings report, indicating some investor caution ahead.
HeartFlow's stock remains steady with a slight gain on Pluang, trading at USD 47.10 and up 0.51% as of Nov 18, 2026 03:41 WIB. The stock's market cap stands at $4.12 billion, reflecting ongoing investor interest despite recent volatility.